Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

6.622 +0.022 (+0.33%)
Streaming Delayed Price Updated: 11:20 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference
From Mind Medicine (MindMed) Inc.
Via Business Wire
MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates
From Mind Medicine Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
MindMed to Report First Quarter 2025 Financial Results on May 8, 2025
From Mind Medicine (MindMed) Inc.
Via Business Wire
New Study Shows Ibogaine Can Be Made Without Using Plant Matter
Via Investor Brand Network
Why Mind Medicine Stock Is Skyrocketing Today
Via The Motley Fool
Why Mind Medicine Stock Is Soaring Today
Via The Motley Fool
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
From Mind Medicine (MindMed) Inc.
Via Business Wire
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
Study Finds That the Mental Wellbeing Effects of Psilocybin Vary by Race
Via Investor Brand Network
MindMed Appoints Matt Wiley as Chief Commercial Officer
From Mind Medicine Inc.
Via Business Wire
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish
The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier. 
Via Stocktwits
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
From Mind Medicine Inc.
Via Business Wire
MindMed to Present at Leerink’s Global Healthcare Conference 2025
From Mind Medicine Inc.
Via Business Wire
Earnings Scheduled For March 6, 2025
Via Benzinga
Warren Buffett's State of the Market
Berkshire's cash hoard is approaching "Dr. Evil" levels. 
Via The Motley Fool
Groups of Military Veterans Urge Congress to Expedite Research on Psychedelics
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
From Mind Medicine Inc.
Via Business Wire
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months
Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca. 
Via Stocktwits
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks. 
Via Investor's Business Daily
MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
From Mind Medicine Inc.
Via Business Wire
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
From Mind Medicine (MindMed) Inc.
Via Business Wire
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish
The brokerage also pointed to potential large-scale expansion opportunities and emphasized the growing acceptance of psychedelics in future treatment paradigms. 
Via Stocktwits
This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
MindMed to Be Added to the Nasdaq Biotechnology Index
From Mind Medicine (MindMed) Inc.
Via Business Wire
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
From Mind Medicine (MindMed) Inc.
Via Business Wire
MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
From Mind Medicine
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback